Physician
Jules Stein Eye Institute Medical Group
Jules Stein Eye Institute Medical Group was paid $2.16M by Medicaid between Jan 2018 and Dec 2024, across 33 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 21% of everything it billed.
33Billing provider infoJULES STEIN EYE INSTITUTE MEDICAL GROUP
LOS ANGELES, CA 90095
LOS ANGELES, CA 90095
33aNPI1326006966assigned 05/03/2006
33bProvider typeOphthalmology Physician
28Total paid$2.16M
24GClaims59,961
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in California
Rank by total paid#53 of 759
Median peer was paid$35K
This provider vs. median61×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HALE, KATHERINE controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,718 | $121K | |
| 2019 | 9,280 | $297K | |
| 2020 | 7,651 | $248K | |
| 2021 | 10,176 | $338K | |
| 2022 | 8,486 | $380K | |
| 2023 | 7,425 | $345K | |
| 2024incomplete | 10,225 | $430K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 21% | 6,469 | 5,707 | $463K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 11% | 1,001 | 929 | $242K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 11% | 9,263 | 8,527 | $229K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 10% | 6,598 | 6,439 | $217K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.8% | 4,121 | 3,941 | $211K |
| J0178 | Injection, aflibercept, 1 mg | 8.0% | 277 | 250 | $174K |
| 92134 | 7.9% | 11,221 | 10,762 | $171K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.9% | 3,178 | 2,998 | $85K |
| 92083 | 3.5% | 4,087 | 4,052 | $75K | |
| 92250 | 3.1% | 3,565 | 3,498 | $66K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 2.5% | 1,123 | 1,118 | $54K |
| 92133 | 2.4% | 3,678 | 3,624 | $53K |
21 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.5% | 466 | $33K |
| 92136 | 1.1% | 1,144 | $24K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 310 | $16K |
| J7999 | Compounded drug, not otherwise classified | <1% | 486 | $13K |
| 92060 | <1% | 244 | $10K | |
| 76512 | <1% | 230 | $5K | |
| 76514 | <1% | 1,025 | $3K | |
| 92020 | <1% | 361 | $3K | |
| 92201 | <1% | 392 | $2K | |
| 99221 | <1% | 52 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 41 | $2K |
| 66821 | <1% | 14 | $1K | |
| 92015 | Determination of refractive state | <1% | 82 | $1K |
| 92285 | <1% | 122 | $952.39 | |
| 92226 | <1% | 114 | $828.59 | |
| 99205 | Prolong outpt/office vis | <1% | 14 | $397.08 |
| 92025 | <1% | 26 | $389.76 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 15 | $372.54 |
| 1160F | 0% | 70 | $0.00 | |
| 1159F | 0% | 139 | $0.00 | |
| 2022F | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHALE, KATHERINE (DIRECTOR OF ACCOUNTING)
| Provider | Location | Paid |
|---|---|---|
| The Regents of the University of California | Los Angeles, CA | $35.81M |
| Regents of the Univ of Ca Emer Med | Los Angeles, CA | $7.58M |
| Regents University of California | Santa Monica, CA | $7.36M |
| The Regents of the University of California | Los Angeles, CA | $1.72M |
| Regents of the University of California | Los Angeles, CA | $1.58M |
| Regents of the University of California | Van Nuys, CA | $611K |
| Regents of the University of California | Los Angeles, CA | $287K |
| Uc Regents | Santa Monica, CA | $231K |
| Regents of the University of California Los Angeles | Los Angeles, CA | $201K |
| The Regents of the University of California | Los Angeles, CA | $191K |
| UCLA Associated General Surgeons | Los Angeles, CA | $170K |
| The Regents of the University of California | Los Angeles, CA | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.